[1] Mayinger B,Hensen J. Nonpeptide Vasopressin Antagonists:A New Group of Hormone Blockers Entering the Scene[J]. Exp Clin Endocrinol Diabetes,1999,107:157-165.[2] LU Zhicheng. Conivaptan Hydrochloride:Non-peptide Dual Inhibitor[J]. Med Econ News,A06,2006(in Chinese).陆志成. 盐酸考尼伐坦:非肽类双重抑制剂[J]. 医药经济报,第A06版,药物评价,2006.[3] Tanaka A,Koshio H,Tanigudhi N,et al. (Yamanouchi Pharmaceutical Co,Ltd.). Fused Benzazepine Derivative and Pharmaceutical Composion Containing the Same:EP,0709386,JP,1995505056,US,5723606,WO,9503305[P].[4] Yamazaki A,Tanaka A,Tsunoda T. (Yamanouchi Pharmaceutical Co,Ltd.). Novel Preparation Method of Condense Benzazepine Derivatives:JP,1996198879[P].[5] Tsunoda T,Yamazaki A,Mase T,et al. A Scalable Process for the Synthesis of 2-Methyl-1,4,5,6- tetrahydroimidazo[4,5-d][1] Benzazepine Monohydrate and 4-[(Biphenyl -2- ylcarbonyl) Amino] Benzoic Acid:Two New Key Intermediates for the Synthesis of the AVP Antagonist Conivaptan Hydrochloride[J]. Org Process Res Dev,2005,9:593-598.[6] Takashi Tsunoda,Akihiro Tanaka,Toshiyasu Mase,et al. A New Synthetic Route to YM087, An Arginine Vasopressin Antagonist[J]. Heterocycles,2004,63(5):1113-1122.[7] Proctor G R,Thomson R H. Diecknmnn Cyclisation of Dry Lamino-esters[J]. J Chem Soc,1957:2312.[8] Hirota T,Fukumoto M,Sasaki K,et al. Synthesis of Novel Ring System, 4H-Imidazo [l′,2′:l,6]pyrimido [5,4-d][1]Benzazepine as B-Homo-6.11,13,15-tethaazastrhoidal Analogue[J]. Heterocycles,1986,24:143. |